BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11681514)

  • 21. Low-dose tamoxifen retinopathy.
    Chang T; Gonder JR; Ventresca MR
    Can J Ophthalmol; 1992 Apr; 27(3):148-9. PubMed ID: 1586887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological findings in paraneoplastic retinopathy.
    Matsui Y; Mehta MC; Katsumi O; Brodie SE; Hirose T
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):324-8. PubMed ID: 1505762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ERG diagnosis and differential diagnosis: results of examination over 6 years].
    Stemeyer G; Stähli P
    Klin Monbl Augenheilkd; 1996 May; 208(5):306-10. PubMed ID: 8766035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction.
    Kellner U; Kraus H; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):94-7. PubMed ID: 10664060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multifocal electroretinogram (MF-ERG) in diagnosis of macular changes. Example: senile macular degeneration].
    Palmowski AM; Sutter EE; Bearse MA; Fung W
    Ophthalmologe; 1999 Mar; 96(3):166-73. PubMed ID: 10234964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
    So SC; Hedges TR; Schuman JS; Quireza ML
    Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TAMOXIFEN RETINOPATHY DURING TREATMENT OF AN INOPERABLE DESMOID TUMOR.
    Furst M; Somogyi MB; Wong RW; Araujo D; Harper CA
    Retin Cases Brief Rep; 2020; 14(3):268-270. PubMed ID: 29227350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Senile panretinal cone dysfunction in age-related macular degeneration (AMD): a report of 52 amd patients compared to age-matched controls.
    Ronan S; Nusinowitz S; Swaroop A; Heckenlively JR
    Trans Am Ophthalmol Soc; 2006; 104():232-40. PubMed ID: 17471344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal changes associated with tamoxifen treatment for breast cancer.
    Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
    Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen retinopathy in a male patient.
    Yanyali AC; Freund KB; Sorenson JA; Slakter JS; Wheatley HM
    Am J Ophthalmol; 2001 Mar; 131(3):386-7. PubMed ID: 11239879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retinal damage by (hydroxy)chloroquine intake: published evidence for an efficient ophthalmological follow-up].
    Pluta JP; Rüther K
    Klin Monbl Augenheilkd; 2009 Nov; 226(11):891-6. PubMed ID: 19916149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of mf-ERG in the Diagnosis and Treatment of Age-Related Macular Degeneration: Electrophysiological Features of AMD.
    Moschos MM; Nitoda E
    Semin Ophthalmol; 2018; 33(4):461-469. PubMed ID: 28328288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alström syndrome--a case report and literature review.
    Karska-Basta I; Kubicka-Trzaska A; Filemonowicz-Skoczek A; Romanowska-Dixon B; Kobylarz J
    Klin Oczna; 2008; 110(4-6):188-92. PubMed ID: 18655459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical maculopathy and retinopathy in transcobalamin deficiency: a 10-year follow-up.
    Rigaudière F; Nasser H; Delouvrier E; Milani P; Schiff M
    Doc Ophthalmol; 2022 Feb; 144(1):53-65. PubMed ID: 34491492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERG campimetry using a multi-input stimulation technique for mapping of retinal function in the central visual field.
    Kretschmann U; Rüther K; Usui T; Zrenner E
    Ophthalmic Res; 1996; 28(5):303-11. PubMed ID: 8979279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
    Guy J; Aptsiauri N
    Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A possible early sign of hydroxychloroquine macular toxicity.
    Brandao LM; Palmowski-Wolfe AM
    Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
    Salomão SR; Watanabe SE; Berezovsky A; Motono M
    Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory Tamoxifen-Induced Keratopathy Despite Drug Withdrawal.
    Andreanos K; Oikonomakis K; Droutsas K; Petrelli M; Kymionis G
    Cornea; 2017 Mar; 36(3):377-378. PubMed ID: 27918356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bull's-eye maculopathy and negative electroretinogram.
    Miyake Y; Shiroyama N; Horiguchi M; Saito A; Yagasaki K
    Retina; 1989; 9(3):210-5. PubMed ID: 2595114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.